Sinopharm Group Co., Ltd. (600420.SH) subsidiary Lornoxicam Hydrochloride Injection receives drug registration certificate.

Wisdom Financial News APP News, China National Pharmaceutical Group Co., Ltd. (600420.SH) announced recently that its wholly-owned subsidiary, China National Pharmaceutical Group Industrial Co., Ltd. (referred to as China Pharmaceutical Industry), has received the "Drug Registration Certificate" for Ketamine Hydrochloride Injection issued by the National Medical Products Administration. This registration certificate is considered to be obtained through consistency evaluation, which will further enrich the company's product portfolio in the anesthesia and analgesia sector, and help enhance the company's comprehensive market competitiveness in the relevant medical fields.